Cardiome Pharma Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (56)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: 3SBio Acquires Wansheng Pharma For $85 Million
Article By: ChinaBio® Today
Saturday, July 25, 2015 3:00 PM EDT
3SBio of Shenyang acquired Zhejiang Wansheng Pharma, a small molecule drugmaker, for $85 million. Wansheng is approved to market 55 products in the areas of oncology, diabetes, cardiovascular and dermatology.
In this article: CASI, CRME, SPPI
Read
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
Article By: Bull Boy
Wednesday, January 21, 2015 6:20 PM EDT
This cash-generating bio-pharma is heading for a positive trajectory in 2015 and beyond.
In this article: CRME, MRK
Read
Week In Review: Otsuka Pays $78 Million For Asian Rights To Ariad's Leukemia Drug
Article By: ChinaBio® Today
Sunday, December 28, 2014 6:01 AM EDT
Otsuka will pay $77.5 million upfront plus additional regulatory milestones. Ariad will receive a "substantial" share of net product revenues.
In this article: ARIA, CRME, CRPNF, THXBY, OTSKF
Read
All Posts

Latest Tweets for $CRME

No tweets yet!

PARTNER HEADLINES